Inovio, NIH to develop swine flu vaccine – Reuters
Posted on 10 August 2009 by FLU
Inovio, NIH to develop swine flu vaccine Reuters Aug 10 (Reuters) – DNA-based vaccine maker Inovio Biomedical Corp (INO.A) said it will jointly develop universal influenza vaccines, including that for H1N1 swine flu strains, with the National Institutes of Health’s (NIH) research unit, … Vaccination Collaboration: Inovio Teams Up With NIH San Diego Business Journal Inovio Rallies As Vaccine Firm In H1N1 Deal With NIH Wall Street Journal Inovio Biomedical Corp. (AMEX:INO) Is The Top Stock Mover TransWorldNews (press release) Philadelphia Inquirer
Related posts:
- Inovio, NIH collaborating on flu vaccines – Bizjournals.com Inovio, NIH collaborating on flu vaccines Bizjournals.com Under the...
- Inovio, NIH collaborating on flu vaccines – Bizjournals.com Inovio, NIH collaborating on flu vaccines Bizjournals.com Under the...
- Inovio Biomedical and NIH Vaccine Research Center Sign Research Collaboration Agreement to Develop Universal Influenza Vaccines SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex:INO), a leader in...
- Inovio Biomedical Universal DNA Vaccine for Chikungunya Virus Demonstrates Protective Antibody Responses in Monkey Model SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader...
- Inovio assesses vaccine against swine flu Inovio Biomedical, National Microbiology Laboratory, and University of Pennsylvania to...
Related posts brought to you by Yet Another Related Posts Plugin.
Tags | biomedical, collaboration, disease, health, inovio-rallies, news-articles, research-unit, spreading-fast, stock-mover, swine flu symptoms, vaccine-maker, virus

